AI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-Cap
AI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-Cap
Check-Cap Ltd (NASDAQ:CHEK) shares are trading higher after Nobul AI Corp, on Monday, agreed to acquire Check-Cap, under which the shareholders of Nobul will become the majority holders of the combined company.
Check-Cap Ltd（納斯達克股票代碼：CHEK）股價走高，此前Nobul AI Corp週一同意收購Check-Cap，根據該收購，Nobul的股東將成爲合併後的公司的大股東。
If completed, the business combination will create a public company headquartered in Toronto, Canada, focused on an AI-driven fintech marketplace and buying and AI-enabling traditional companies to generate higher returns for their shareholders.
業務合併完成後，將創建一家總部位於加拿大多倫多的上市公司，專注於人工智能驅動的金融科技市場，並收購和支持人工智能的傳統公司，爲其股東創造更高的回報。
In connection with the transaction, the combined company will apply for listing on the NASDAQ and TSX.
在本次交易中，合併後的公司將申請在納斯達克和多倫多證券交易所上市。
The executive team of Nobul will serve as the executive team of the combined company, led by Regan McGee, Nobul's Founder, Chief Executive Officer, and Chairman.
Nobul的執行團隊將作爲合併後的公司的執行團隊，由Nobul的創始人、首席執行官兼董事長里根·麥吉領導。
"Following a comprehensive and thorough review of strategic alternatives, Check-Cap's Board of Directors concluded that the proposed transaction with Nobul is in the best interest of our shareholders. We intend to hold a special meeting of Check-Cap shareholders in the coming months to vote on this business combination," said Paul Medeiros, Chairman of the Board of Directors of Check-Cap.
“在對戰略選擇進行了全面徹底的審查之後，Check-Cap董事會得出結論，與Nobul的擬議交易符合我們股東的最大利益。我們打算在未來幾個月內舉行一次Check-Cap股東特別會議，對這種業務合併進行投票。” Check-Cap董事會主席保羅·梅德羅斯說。
"The proposed business combination with Check-Cap is expected to be a transformative step forward in the execution of our mission to deliver value to our shareholders. Nobul has a proven track record of successful M&A and PE transactions, and this merger will give us a platform to pursue many more of these opportunistic transactions as a public company," stated Mr. McGee.
“與Check-Cap的擬議業務合併有望成爲我們履行爲股東創造價值的使命向前邁出的變革性一步。Nobul在成功的併購和私募股權交易方面有着良好的記錄，此次合併將爲我們提供一個平台，讓我們可以作爲上市公司進行更多此類機會主義交易，” 麥吉說。
Nobul is an AI-driven fintech company offering a category-leading technology solution for home buyers and sellers.
Nobul是一家人工智能驅動的金融科技公司，爲購房者和賣家提供類別領先的技術解決方案。
Check-Cap is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening by introducing C-Scan, a preparation-free screening test to detect polyps before they may transform into colorectal cancer and enable early intervention and cancer prevention.
Check-Cap是一家臨床階段的醫療診斷公司，旨在通過引入C-Scan來重新定義結直腸癌（CRC）篩查。C-Scan是一種無需準備的篩查測試，可以在息肉轉化爲結直腸癌之前對其進行檢測，並實現早期干預和癌症預防。
C-Scan is an investigational device and is not available for sale in the United States.
C-Scan 是一種研究設備，不在美國出售。
Price Action: CHEK shares are up 36.9% at $2.69 during the premarket session on the last check Tuesday.
價格走勢：在週二最後一次盤前交易中，CHEK股價上漲36.9％，至2.69美元。
Photo via Shutterstock
照片來自 Shutterstock
譯文內容由第三人軟體翻譯。